Sign in
Jessica

Jessica

Managing Director and Senior Equity Research Analyst at Raymond James Financial Inc.

Indianapolis, IN, US

Jessica Fye is a Managing Director and Senior Equity Research Analyst at Raymond James & Associates, specializing in biotechnology and pharmaceuticals. She covers a portfolio of companies including Gilead Sciences, Vertex Pharmaceuticals, Alnylam Pharmaceuticals, and Amgen, and has established a strong track record for actionable investment calls with a TipRanks success rate historically above 60%. Jessica began her equity research career in the early 2010s, previously working at J.P. Morgan before joining Raymond James in 2017 where she advanced to her current leadership role. She is FINRA-registered, holding Series 7, 63, 86, and 87 licenses, and has been recognized multiple times by Institutional Investor for her research excellence.

Jessica's questions to Paylocity Holding (PCTY) leadership

Question · Q1 2026

Jessica from Raymond James asked whether Paylocity's increasingly differentiated platform value is leading customers to initially adopt more products than previous cohorts, or if it primarily offers more entry points for customers to land and then expand later.

Answer

Toby Williams, President and CEO, confirmed that Paylocity is observing both trends. He stated that platform differentiation aids overall client acquisition and unit growth, while also noting a consistent year-over-year increase in the number of products clients adopt, leading to higher average revenue per user (ARPU) at acquisition and through subsequent cross-selling.

Ask follow-up questions

Fintool

Fintool can predict Paylocity Holding logo PCTY's earnings beat/miss a week before the call

Question · Q1 2026

Jessica asked if Paylocity's increasingly differentiated platform is leading customers to land with more products initially, or if it primarily offers more entry points for later expansion.

Answer

President and CEO Toby Williams observed both trends: differentiation gains aiding client acquisition and unit growth, and a long-term increase in average revenue per client (ARPU) as clients adopt more products over time, both at acquisition and through cross-sells.

Ask follow-up questions

Fintool

Fintool can write a report on Paylocity Holding logo PCTY's next earnings in your company's style and formatting

Jessica's questions to Samsara (IOT) leadership

Question · Q2 2026

Jessica inquired about any structural differences in the international opportunity and competitive environment compared to domestic growth, and whether competitors are becoming more aggressive on pricing.

Answer

Sanjit Biswas (CEO) noted consistent competitors (point solutions, regional players) and differentiated Samsara through its platform approach and value unlock. He acknowledged competitors often discount heavily but stated Samsara focuses on demonstrating greater value beyond just price.

Ask follow-up questions

Fintool

Fintool can predict Samsara logo IOT's earnings beat/miss a week before the call

Let Fintool AI Agent track Jessica for you

Get briefed when they ask questions on calls

Best AI Agent for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Try Fintool for free